|
PUBLISHED BY OUR CUSTOMERS
Lang L, Loveless R, Dou J, Lam T, Chen A, Wang F, Sun L, Juarez J, Qin ZS, Saba BF, Shay C and Teng Y. ATAD3A mediates activation of RAS-independent mitochondrial ERK1/2 signaling, favoring head and neck cancer development.
J Exp Clin Cancer Res 41, 43. 2022. DOI: 10.1186/s13046-022-02274-9 Shay C. and Teng Y. Evaluating the Anticancer Activity of Natural Products Using a Novel 3D Culture Model. In: Guest P.C. (eds) Physical Exercise and Natural and Synthetic Products in Health and Disease.
Methods in Molecular Biology, vol 2343, 2022. Humana, New York, NY. DOI: 10.1007/978-1-0716-1558-4_9 https://link.springer.com/protocol/10.1007/978-1-0716-558-4_9
Lang L, Wang F, Ding Z, Zhao X, Loveless R, Xie J, Shay C, Qiu P, Ke Y, Saba NF, Teng Y. Blockade of glutamine-dependent cell survival augments antitumor efficacy of CPI-613 in head and neck cancer.
J Exp Clin Cancer Res. 2021 Dec 14;40(1):393. DOI: 10.1186/s13046-021-01888-9 Lang L, Xiong Y, Prieto-Dominguez N, Loveless R, Jensen C, Shay C, Teng Y. FGF19/FGFR4 signaling axis confines and switches the role of melatonin in head and neck cancer metastasis.
J Exp Clin Cancer Res. 2021 Mar 10;40(1):93. DOI: 10.1186/s13046-021-01888-9 Mamouni K, Kim J, Lokeshwar BL, Kallifatidis G. ARRB1 Regulates Metabolic Reprogramming to Promote Glycolysis in Stem Cell-Like Bladder Cancer Cells.
Cancers (Basel). 2021 Apr 10;13(8):1809. DOI: 10.3390/cancers13081809 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8069028/
Teng Y, Cho WC. Editorial: Going the Distance: Enabling 3D Cell Culture Systems for Biomedical Research and Drug Treatment.
Front Mol Biosci. 2021 May 10;8:685095. DOI: 10.3389/fmolb.2021.685095 Gao L, Xu Z, Huang Z, Tang Y, Yang D, Huang J, He L, Liu M, Chen Z, Teng Y. CPI-613 rewires lipid metabolism to enhance pancreatic cancer apoptosis via the AMPK-ACC signaling.
J Exp Clin Cancer Res. 2020 Apr 28;39(1):73. DOI: 10.1186/s13046-020-01579-x Lang L, Lam T, Chen A, Jensen C, Duncan L, Kong FC, Kurago ZB, Shay C, Teng Y. Circumventing AKT-Associated Radioresistance in Oral Cancer by Novel Nanoparticle-Encapsulated Capivasertib.
Cells. 2020 Feb 25;9(3):533. DOI: 10.3390/cells9030533 Vo-Hoang Y, Paiva S, He L, Estaran S, Teng Y. Design and Synthesis of Arf1-Targeting γ-Dipeptides as Potential Agents against Head and Neck Squamous Cell Carcinoma.
Cells. 2020 Jan 24;9(2):286. DOI: 10.3390/cells9020286 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072570/
Shay C., Lang L., Teng Y. (2020) Visualizing and Evaluating Cancer Cell Growth and Invasion by a Novel 3D Culture System. In: Guest P. (eds) Clinical and Preclinical Models for Maximizing Healthspan.
Methods in Molecular Biology, vol 2138. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-0471-7_9
Caleb J and Teng Y. Is It Time to Start Transitioning From 2D to 3D Cell Culture?
Front. Mol. Biosci. 2020, 6:33 DOI: 10.3389/fmolb.2020.00033 www.frontiersin.org/articles/10.3389/fmolb.2020.00033/full
Miller PG, Chen CY, Wang YI, Gao E, Shuler ML. Multiorgan microfluidic platform with breathable lung chamber for inhalation or intravenous drug screening and development.
Biotechnol Bioeng. 2020 Feb;117(2):486-497. DOI: 10.1002/bit.27188 Lang L, Shay C, Zhao X, Xiong Y, Teng Y. Simultaneously inactivating Src and AKT by saracatinib/capivasertib co-delivery nanoparticles to improve the efficacy of anti-Src therapy in head and neck squamous cell carcinoma.
J Hematol Oncol. 2019, 12:132. DOI:10.1186/s13045-019-0827-1 
Xiong Y, He L, Shay C, Lang L, Loveless J, Yu J, Chemmalakuzhy R, Jiang H, Liu M, Teng Y. Nck-associated Protein 1 Associates with HSP90 to Drive Metastasis in Human Non-Small-Cell Lung Cancer.
J Exp Clin Cancer Res. 2019, 38(1):122. DOI: 10.1186/s13046-019-1124-0
Morrissey B, Blyth K, Carter P, Chelala C, Holen I, Jones L, Speirs V. SEARCHBreast Workshop Proceedings: 3D Modelling of Breast Cancer.
Altern Lab Anim. 2015 Dec;43(6):367-75. DOI: 10.1177/026119291504300604 |
AUTHORED BY LENA BIOSCIENCES AND COLLABORATORS
Shoemaker J.T., Zhang W., Atlas A.I., Bryan R.A., Inman S.W., Vukasinovic J. A 3D Cell Culture Organ-on-a-Chip Platform With a Breathable Hemoglobin Analogue Augments and Extends Primary Human Hepatocyte Functions in vitro.
Frontiers in Molecular Biosciences. 2020. DOI: 10.3389/fmolb.2020.568777 C. M. Didier, A. Kundu, J. T. Shoemaker, J. Vukasinovic and S. Rajaraman. SeedEZTM Interdigitated Electrodes and Multifunctional Layered Biosensor Composites (MLBCs): A Paradigm Shift in the Development of In Vitro BioMicrosystems. J Microelectromech S. 2020
DOI: 10.1109/JMEMS.2020.3003452 In vitro hepatocyte function is enhanced in a perfused 3D culture platform. James T. Shoemaker, Wanrui Zhang, Dennis G. McDuffie, Alejandro Badilla, Emmanuel Thomas, Jelena Vukasinovic.
Life Science Exhibits’ Virtual Conference: Immunology | Infectious Disease | COVID-19 2020.
Shoemaker JT, Richardson KR, Arnst J, Marcus AI and Vukasinovic J. Characterization of patient-derived organoids cultured on a gas-rich, liquid-liquid interface.
American Association for Cancer Research 2019. Proceedings: Abstracts 1-2748 DOI: 10.1158/1538-7445.AM2019-54
J.T. Shoemaker, J. Vukasinovic, C. Xu, Z. Wen, and M.C. LaPlaca. Neuroimmune activation and off-target toxicity testing of cell therapies using a novel brain-on-a-chip system.
Society for Neuroscience 2018.
J. Vukasinovic, J.T. Shoemaker, and M.C. LaPlaca. A perfused three-dimensional culture model of human cortical tissue.
Society for Neuroscience 2018.
Sophie Roberts, Danah Al’Qallaf, Sally A. Peyman, Darren Tomlinson, J.T. Shoemaker, Jelena Vukasinovic and Valerie Speirs. Progress towards the development of a fully humanised 3D cell culture model of HER2+ breast cancer.
Breast Cancer Res Treat (2018) 167: 309. DOI: 10.1007/s10549-017-4585-x Shoemaker J.T. and Vukasinovic J. Cytochrome P450 enzyme activity is enhanced in hepatocytes grown using a perfused 3D cell culture drug screening system.
American Association for Cancer Research 2017. Volume 77, Issue 13 Supplement, pp. 4080. DOI: 10.1158/1538-7445.AM2017-4080
Shoemaker J.T. and Vukasinovic J. A perfused 3D cell culture platform for preclinical drug screening.
New Frontiers in 3D Cell Culture-based Screening Technologies. October 13, 2016. Baltimore, MD, USA
| ||||||||||||||||
Learn about 3D cell culture and Perfused Organ Panel technology
Learn about 3D cell culture and Perfused Organ Panel technology
Copyright © 2020